X
CHMP says no to Amgen’s osteoporosis drug Evenity
https://pharmaphorum.com/news/chmp-says-no-to-amgens-osteoporosis-drug-evenity/
UCB
FDA approves UCB’s Cimzia in plaque psoriasis
The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis